Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Location: Brussels Position type: Fixed-Term Contract (12 months), Full-Time, Hybrid working (2–3 days in the office) What the hiring manager says This is a unique opportunity to become one of the founding members of M4Ds newly
Europcar Mobility Group At Europcar Mobility Group, our purpose is to help to change the way you move. We are guided by our core values: We are happy to help, We embrace change, We take responsibility,
About the European Climate Foundation The European Climate Foundation (ECF) is a major philanthropic initiative working to help tackle the climate crisis by fostering the development of a net-zero emission society at the national, European and